The previous post about the Scenesse treatment has sparked a lot of interest and many questions about the process. I was contacted by phone this week by a Director from Clinuvel. We had a wonderful conversation; most impressive was

A drug initially developed to protect skin from light and UV will soon be tested as a repigmentation therapy in vitiligo

ReCell® is a stand-alone, rapid, autologous cell harvesting, processing and delivery technology that enables surgeons and clinicians to treat skin defects using the patient’s own cells in a regenerative process. (Vitiligo results here, about halfway down page)
Developed as an ‘off the shelf’ kit, ReCell enables a thin split thickness biopsy, taken at the time of the procedure, to be processed into an immediate cell population for delivery onto the surface of the treatment area using a highly efficient, easy-to-use proprietary ’spray-on’ application process. …